Evogliptin tartrate
Product Specifications
CAS Number
1222102-51-3
Target
Proteasome, Autophagy, DPP-4
Related Pathways
Proteases/Proteasome, Autophagy, Ubiquitination
Bioactivity
Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation. Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity.
Smiles
O[C@H]([C@@H](O)C(O)=O)C(O)=O.CC(C)(C)OC[C@H]1N(CCNC1=O)C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F
Molecular Formula
C23H32F3N3O9
Molecular Weight
551.51
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15268731 1 Vial
Lentiviral mouse Ago3 shRNA (UAS) - Lentiviral mouse Ago3 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 
280883-01 50 mg
2-Imidazol-1-yl-1-methyl-ethylamine dihydrochloride
Sign In for Pricing
View Details 280883-02 100 mg
2-Imidazol-1-yl-1-methyl-ethylamine dihydrochloride
Sign In for Pricing
View Details